Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection
- PMID: 31443253
- PMCID: PMC6721674
- DOI: 10.3390/cells8080902
Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection
Abstract
HIV-1 disseminates to a broad range of tissue compartments during acute HIV-1 infection (AHI). The central nervous system (CNS) can serve as an early and persistent site of viral replication, which poses a potential challenge for HIV-1 remission strategies that target the HIV reservoir. CNS compartmentalization is a key feature of HIV-1 neuropathogenesis. Thus far, the timing of how early CNS compartmentalization develops after infection is unknown. We examined whether HIV-1 transmitted/founder (T/F) viruses differ between CNS and blood during AHI using single-genome sequencing of envelope gene and further examined subregions in pol and env using next-generation sequencing in paired plasma and cerebrospinal fluid (CSF) from 18 individuals. Different proportions of mostly minor variants were found in six of the eight multiple T/F-infected individuals, indicating enrichment of some variants in CSF that may lead to significant compartmentalization in the later stages of infection. This study provides evidence for the first time that HIV-1 compartmentalization in the CNS can occur within days of HIV-1 exposure in multiple T/F infections. Further understanding of factors that determine enrichment of T/F variants in the CNS, as well as potential long-term implications of these findings for persistence of HIV-1 reservoirs and neurological impairment in HIV, is needed.
Trial registration: ClinicalTrials.gov NCT00796146.
Keywords: HIV-1; acute HIV-1 infection (AHI); central nervous system (CNS); cerebrospinal fluid (CSF); compartmentalization; multiple infections; next-generation sequencing (NGS); single-genome amplification (SGA); transmitted/founder (T/F) virus.
Conflict of interest statement
The authors declare no conflict of interest. G.H.K is currently employed by GSK Vaccines but his participation in this study precedes the current employment.
Figures



References
-
- Ananworanich J., Schuetz A., Vandergeeten C., Sereti I., de Souza M., Rerknimitr R., Dewar R., Marovich M., van Griensven F., Sekaly R., et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS ONE. 2012;7:e33948. doi: 10.1371/journal.pone.0033948. - DOI - PMC - PubMed
-
- Valcour V., Chalermchai T., Sailasuta N., Marovich M., Lerdlum S., Suttichom D., Suwanwela N.C., Jagodzinski L., Michael N., Spudich S., et al. Central nervous system viral invasion and inflammation during acute HIV infection. J. Infect. Dis. 2012;206:275–282. doi: 10.1093/infdis/jis326. - DOI - PMC - PubMed
-
- Fletcher C.V., Staskus K., Wietgrefe S.W., Rothenberger M., Reilly C., Chipman J.G., Beilman G.J., Khoruts A., Thorkelson A., Schmidt T.E., et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl. Acad. Sci. USA. 2014;111:2307–2312. doi: 10.1073/pnas.1318249111. - DOI - PMC - PubMed
-
- Peluso M.J., Ferretti F., Peterson J., Lee E., Fuchs D., Boschini A., Gisslen M., Angoff N., Price R.W., Cinque P., et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012;26:1765–1774. doi: 10.1097/QAD.0b013e328355e6b2. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous